Contact
searchSearch
HMP Global

June 2013 - FRMC

Department
Human Insulin Analog to Treat Diabetes
06/26/2013
The FDA approved Humalog® (insulin lispro) in June 1996 to improve glycemic control in adults and children with diabetes. The drug, a rapid acting human insulin analog, is marketed by Eli Lilly and Company. Insulin lispro comes in various...
The FDA approved Humalog® (insulin lispro) in June 1996 to improve glycemic control in adults and children with diabetes. The drug, a rapid acting human insulin analog, is marketed by Eli Lilly and Company. Insulin lispro comes in various...
The FDA approved Humalog®...
06/26/2013
First Report Managed Care
Treating Castrate-Resistant Prostate Cancer
06/26/2013
Orlando—Although the prevalence of prostate cancer is stable, it remains the most common cancer for men. The introduction of new therapies has led to improved survival rates, but most men must take several agents to treat the disease,...
Orlando—Although the prevalence of prostate cancer is stable, it remains the most common cancer for men. The introduction of new therapies has led to improved survival rates, but most men must take several agents to treat the disease,...
Orlando—Although the prevalence...
06/26/2013
First Report Managed Care
Evolving Treatment Strategies for Myeloma
06/26/2013
Orlando—Since 2000, the number of treatments for myeloma has expanded with the introduction of proteasome inhibitors and other immunomodulatory agents. Still, the disease is complex, and there are multiple options available for the treatment...
Orlando—Since 2000, the number of treatments for myeloma has expanded with the introduction of proteasome inhibitors and other immunomodulatory agents. Still, the disease is complex, and there are multiple options available for the treatment...
Orlando—Since 2000, the number...
06/26/2013
First Report Managed Care

Department

News Connection
Injectable Therapy Receives Expanded Approval for Ulcerative Colitis
06/26/2013
The FDA expanded the approval of Simponi®(golimumab) in May 2013 to treat adults with moderately to severely active ulcerative colitis. The drug, an injectable anti-tumor necrosis factor-alpha treatment from Janssen Biotech, Inc, is also...
The FDA expanded the approval of Simponi®(golimumab) in May 2013 to treat adults with moderately to severely active ulcerative colitis. The drug, an injectable anti-tumor necrosis factor-alpha treatment from Janssen Biotech, Inc, is also...
The FDA expanded the approval of...
06/26/2013
First Report Managed Care
Conference Insider
Pathologic Myopia and Retinal Neovascularization
06/26/2013
New Orleans—An analysis of a claims database in the United States, which covers >25 million lives annually, found that the incidence of pathologic myopia (PM) was 2.75 per 10,000 individuals in 2011, while the prevalence of PM was 9.64 per...
New Orleans—An analysis of a claims database in the United States, which covers >25 million lives annually, found that the incidence of pathologic myopia (PM) was 2.75 per 10,000 individuals in 2011, while the prevalence of PM was 9.64 per...
New Orleans—An analysis of a...
06/26/2013
First Report Managed Care
Conference Insider
Savings from Preventing Comorbid Conditions in Obese Patients
06/26/2013
Patients who took the extended release combination of phentermine and topiramate and modified their lifestyle to manage obesity developed fewer comorbidities than they would have without treatment, according to an economic model. 
Patients who took the extended release combination of phentermine and topiramate and modified their lifestyle to manage obesity developed fewer comorbidities than they would have without treatment, according to an economic model. 
Patients who took the extended...
06/26/2013
First Report Managed Care
Conference Insider
Managed Care for Dual-Eligible Population
06/26/2013
Arlington, Virginia—Of all of the budget issues facing states, among the most pressing is how to pay for healthcare services. States are particularly concerned with providing adequate services and lowering costs of delivering care for dual...
Arlington, Virginia—Of all of the budget issues facing states, among the most pressing is how to pay for healthcare services. States are particularly concerned with providing adequate services and lowering costs of delivering care for dual...
Arlington, Virginia—Of all of...
06/26/2013
First Report Managed Care
Conference Insider
Accountable Care Organizations in Medicaid Programs
06/26/2013
In order to form advantageous Medicaid accountable care organizations (ACOs), proper methods to combat uncoordinated care must first be established.
In order to form advantageous Medicaid accountable care organizations (ACOs), proper methods to combat uncoordinated care must first be established.
In order to form advantageous...
06/26/2013
First Report Managed Care
Conference Insider
Quality Ratings for Medicare Advantage Plans
06/26/2013
Orlando—The Centers for Medicare & Medicaid Services (CMS) introduced its 5 Star Ratings system to hold Medicare Advantage plans responsible for delivering improved care and for providing information to patients to make better decisions....
Orlando—The Centers for Medicare & Medicaid Services (CMS) introduced its 5 Star Ratings system to hold Medicare Advantage plans responsible for delivering improved care and for providing information to patients to make better decisions....
Orlando—The Centers for Medicare...
06/26/2013
First Report Managed Care
Conference Insider
Transitioning Toward a Consumer-Centric Approach in Healthcare
06/26/2013
Orlando—As a partner in Oliver Wyman’s Health & Life Sciences group, Michael Lovdal, PhD, is accustomed to people asking or complaining about the problems associated with healthcare spending. Recently, an acquaintance told him he thought the...
Orlando—As a partner in Oliver Wyman’s Health & Life Sciences group, Michael Lovdal, PhD, is accustomed to people asking or complaining about the problems associated with healthcare spending. Recently, an acquaintance told him he thought the...
Orlando—As a partner in Oliver...
06/26/2013
First Report Managed Care
FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

What's Trending?

News
Adjuvant Anti-VEGF Drugs Unhelpful in Locally Advanced Kidney Cancer
02/23/2015
Adjuvant treatment with either sorafenib or sunitinib is unhelpful in locally advanced resected kidney cancer and should not be pursued.
Adjuvant treatment with either sorafenib or sunitinib is unhelpful in locally advanced resected kidney cancer and should not be pursued.
Adjuvant treatment with either...
02/23/2015
First Report Managed Care
News
Billions in AIDS Relief Spent on Indirect Costs Over a Decade
11/21/2018
Between 2007 and 2016, indirect costs may have accounted for more than $4 billion in international partner funding in the President’s Emergency Plan for AIDS Relief, according to new estimates. 
Between 2007 and 2016, indirect costs may have accounted for more than $4 billion in international partner funding in the President’s Emergency Plan for AIDS Relief, according to new estimates. 
Between 2007 and 2016, indirect...
11/21/2018
First Report Managed Care
News
FDA moves toward tighter medical device oversight
08/04/2010
08/04/2010
First Report Managed Care
Payer Roundtable: The 21st Century Cures Act
01/23/2017
In December 2016, the 21st Century Cures Act was signed into law in an effort to improve the quality, research, and efficacy of health care delivery in the US. 
In December 2016, the 21st Century Cures Act was signed into law in an effort to improve the quality, research, and efficacy of health care delivery in the US. 
In December 2016, the 21st...
01/23/2017
First Report Managed Care
News
Gradual Smoking Cessation May be Possible with Nicotine Addiction Pill
02/17/2015
A nicotine addiction pill can help smokers quit gradually when they can't go cold turkey, a study finds, suggesting that it may be time to revisit practice guidelines that focus primarily on immediate cessation.
A nicotine addiction pill can help smokers quit gradually when they can't go cold turkey, a study finds, suggesting that it may be time to revisit practice guidelines that focus primarily on immediate cessation.
A nicotine addiction pill can...
02/17/2015
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

June 2013 Volume 10 Issue 6

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use